Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 67296-2335

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 67296-2335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxybutynin Chloride Extended-release Tablet (F54e4d4e 91be 4e10 A446 57ed5e1843a1 01)

Chemical structure of oxybutynin hydrochloride, depicting its molecular framework including phenyl, cyclohexyl, and alkyne functional groups linked to a diethylamino moiety with a hydrochloride salt.*

FDA Label Image

Oxybutynin Chloride Extended Release Tablets (F54e4d4e 91be 4e10 A446 57ed5e1843a1 02)

Line graph showing mean plasma R-oxybutynin concentration (ng/mL) over time (hours) comparing oxybutynin chloride extended-release tablets 10 mg once daily (QD) versus oxybutynin 5 mg three times daily (TID). Concentration fluctuates with peaks and troughs illustrated for each dosing regimen over a 24-hour period.*

FDA Label Image

Oxybutynin Chloride Extended Release Tablets (F54e4d4e 91be 4e10 A446 57ed5e1843a1 03)

A line graph showing mean R-oxybutynin plasma concentration (ng/mL) over time (hours) up to 24 hours. The y-axis ranges from 0 to 2.0 ng/mL, and data points represent mean concentrations with error bars at multiple time points between 0 and 24 hours.*

FDA Label Image

Study 1 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 04)

A horizontal error bar chart comparing oxybutynin chloride extended-release tablets and placebo. The x-axis ranges from -40 to 40 with data points plotted around -20 for oxybutynin and near 0 for placebo, each with horizontal error bars indicating variability.*

FDA Label Image

Study 2 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 05)

A horizontal error bar chart comparing two items: 'Oxybutynin chloride extended-release tablets' and 'oxybutynin.' The chart's x-axis ranges approximately from -40 to 40, with data points shown with error bars. The graph visually compares data, likely related to oxybutynin tablet formulations.*

FDA Label Image

Study 3 (F54e4d4e 91be 4e10 A446 57ed5e1843a1 06)

A horizontal error bar chart comparing two items: "Oxybutynin chloride extended-release tablets" and "oxybutynin." The x-axis ranges from -40 to 40, with reference points labeled at -20, 0, 20, and 40. Each item has an associated horizontal line with a central point, indicating a range of values, with the oxybutynin chloride tablets positioned slightly left of zero, and oxybutynin slightly below the tablets.*

FDA Label Image

5 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 07)

Label for Oxybutynin Chloride Extended-Release Tablets USP, 5 mg film-coated extended-release oral tablets. The label shows a package size of 100 tablets, prescription use only, manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. Dosage instructions and storage conditions are partially visible. The label includes a barcode and the NDC 68382-255-01.*

FDA Label Image

10 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 08)

Label for Oxybutynin Chloride extended-release tablets, USP, 10 mg strength. The film-coated tablets are supplied in a container of 100 tablets for oral use. Label shows the active ingredient oxybutynin chloride 10 mg per tablet. Manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes dosage instructions, storage conditions, and safety warnings.*

FDA Label Image

15 mg (F54e4d4e 91be 4e10 A446 57ed5e1843a1 09)

Label for oxybutynin chloride extended-release tablets, USP 15 mg. The film-coated tablets come in a bottle of 100 count. The label includes storage instructions and warnings. Manufactured by Zydus Lifesciences Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. The NDC shown is 68382-257-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.